April 2022- The next generation of automated microwave peptide synthesizers, the Liberty 2.0 instrumentation line, has been released by CEM Corporation, with pride. The Liberty 2.0 series is a further advancement of CEM's highly acclaimed SPPS technology, yielding notable improvements in peptide purity, synthesis efficiency, and automation dependability.
August 2022- Peptides are well-liked active ingredients in cosmeceuticals, which are cosmetic products. Much research on the topic of dermatology has shown that peptides contribute to the maintenance of a youthful and healthy appearance. Because they can boost the formation of dermal extracellular matrix proteins like collagen, they are especially interesting for anti-aging applications. Additionally, studies have demonstrated that several peptides can encourage angiogenesis, cell migration, and wound healing.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 3221
Published Date: Jan 05, 2024
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Growing demand for peptide-based therapeutics, expanding applications, research and development, and supportive government policies are some of the major growth factors for the marketâ€™s growth.
The market size of liquid phase peptide synthesis is anticipated to attain a CAGR of 10 % over the forecast period, i.e., 2024-2036.
The major players in the market are CEM Corporation, Bachem AG, CSBio, Biotage, AnaSpec, ZenBio, Inc., Thermo Fisher Scientific Inc., GenScript, PolyPeptide Group, Sosei Group Corporation, Tokyo Mirai Style Co., Ltd., and others.
The Therapeutics segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.